Acknowledgements The infrastructure for the NESDA study ( is funded through the Geestkracht program of the Netherlands Organisation for Health Research and Development (ZonMw, grant number 10-000-1002) and financial contributions by participating universities and mental health care organizations (VU University Medical Center, GGZ inGeest, Leiden University Medical Center, Leiden University, GGZ Rivierduinen, University Medical Center Groningen, University of Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Rob Giel Onderzoekscentrum)
Cagrilintides focused amylin receptor targeting may offer regulatory advantages through its more predictable mechanism and potentially favourable safety profile
This question has been on our minds since the completion of the STEP-HFpEF trial, says Pandey
Bacteriostatic water itself causes very few side effects
Journal of controlled release: official journal of the Controlled Release Society
Many people use it proactively to support their overall wellness